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The trial was composed of five diets: a fishmeal/fish oil diet, a 20% soybean 48 
meal/30% fishmeal & fish oil diet, a fishmeal/rapeseed oil diet, plant protein 49 
concentrates/fish oil diet, plant protein ingredients/mix of rapeseed oil & fish oil 50 
diet. Atlantic salmon (Salmo salar) was used as experiment species. Traditional 51 
histological approaches  are not comparable between different organs and/or 52 
treatments, mucosal mapping using universally applicable measures is 53 
standardised and can compare different organs and treatments in an unbiased 54 
manner. Sectional orientation is of great importance for traditional histological 55 
approaches, for mucosal mapping the orientation has no effect. 56 
Bases for lamina propria tissue being an aid as an indicator for determination of 57 
physical health were found. LPr showed higher correlations with other measures 58 
than LPwdth. The relationships shown through LPr were more conclusive and 59 
explanatory where LPwdth acted as a supportive measure. In addition, the LPr 60 
seems better suited for integration with the mucosal mapping technique than 61 
LPwdth, since LPwdth seems more sensitive to sectional direction. For that 62 
reason, LPr will create a more well balanced digitalised and automated system 63 
than LPwdth would produce. 64 
 65 
Keywords: Lamina propria, density, ratio, width, diet.  66 
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Fish health in relation to the gastrointestinal tract  87 
Determining fish health is often assessed through fish morphology like biometrics 88 
and/or histology (biological tissue level) or immune response (biological cell and 89 
gene level) (Gatlin, 2007). Mucosal barriers, inflammatory and gene response are 90 
part of the innate immune system of fish (Masso-Silva & Diamond, 2014). The 91 
mucosa serves as a first defence barrier against pathogens or other stressors 92 
(Roberts, 2012; Lazado & Caipang, 2014; Dash et al., 2018; Cabillon & Lazado, 93 
2019). The gastrointestinal tract has shown to respond to dietary stressors 94 
affecting the health of the fish (Van den Ingh et al.,  1991).   95 
 96 
Tissue level 97 
The general build-up of the digestive system includes serosa, muscularis, 98 
submucosa and mucosa. Mucosa features two tissue types, epithelia and lamina 99 
propria. The epithelial tissue includes the lining of the gastrointestinal tract and 100 
is protected by a thin layer of gel-like mucous. Mucous is produced by mucous cells 101 
laying close to the epithelial surface. When the gastrointestinal tract is agitated 102 
mucous cell size and density ratios increases and shortening/flattening of the 103 
intestinal folds can occur (Baeverfjord & Krogdahl 1996).  104 
 105 
Lamina propria is a loose connective tissue underlaying the epithelial tissue. In 106 
healthy conditions the tissue is thin and elongated but changes morphologically 107 
when the gastrointestinal tract is agitated (Ross & Pawlina, 2006). These changes 108 
have been described as widening of the lamina propria tissue (Baeverfjord & 109 
Krogdahl 1996). However, these are often described through histological 110 
observations and lack a consistent quantitative approach (Penn et al., 2011).   111 
 112 
Morphological changes to the mucosa as a whole, and the lamina propria within, 113 
can already be seen after 2 days of gastrointestinal agitation. Even though these 114 
changes were supported later on by actual onset of enteritis, they were too non-115 
specific to be used as a precursor in traditional qualitative histological manners 116 
(Baeverfjord & Krogdahl 1996). However, there are indications that distortion of 117 
lamina propria tissue happens over a longer period of time and indicated that 118 
lamina propria as a tissue undergoes a longer response cascade than discrete acute 119 
responses like inflammatory cells (Van der Sluis et al., 2006).  120 
 121 
Cell level  122 
The lamina propria is often mentioned in relation to gastrointestinal dysfunction 123 
and especially linked to inflammatory diseases (Van der Sluis et al., 2006). Lamina 124 
propria in relation to release of inflammatory cell responses has been well 125 
documented, with leucocytes (mainly lymphocytes) featuring (Baeverfjord & 126 
Krogdahl 1996). Teleost showed to have gut-associated lymphoid tissue (GALT) 127 
that dispersed immune cells (Zapata & Amemiya, 2000) including lymphocytes 128 
(Hellberg et al., 2013; Salinas et al., 2011). As a response to an infection 129 
lymphocyte levels would increase (Abós et al., 2015). Levels of lymphocytes 130 




induced enteritis (Romarheim et al., 2013). Phagocytes provide an immune 132 
response by enveloping pathogens and increases in levels as well when immune 133 
response is activated (Featherstone & Elliss, 1995).  134 
 135 
Gene level  136 
The relative expression of certain genes has been proven to be of aid in the 137 
maintenance or defence of the mucous layer and the underlying mucosa. Mucin is 138 
gradually released from mucous cells (also referred to as goblet cells) to maintain 139 
the mucous layer (Ellis., 2001; Olafsen, 2001). When the gastrointestinal tract is 140 
agitated mucin levels are elevated either through increase and/or acceleration of 141 
production (Torrecillas et al., 2011; Schroers et al., 2009; Plaisancié et al., 1998). 142 
Cathelicidin and defensin are anti-microbial peptides (AMP’s). Immune response 143 
for the relative expression of these genes is triggered by several stressors of which 144 
inflammation is one (Chang et al., 2006).  145 
 146 
Dietary component impacts on gut measures  147 
Many dietary ingredients have been included in fish feed over the years to 148 
substitute different fish derived components. Various neutral, positive or negative 149 
effects have been documented.   150 
 151 
The effect of plant-based oils is still debatable. Replacing fish oil with sunflower 152 
oil indicated a decrease in immune system function for Atlantic salmon (Thompson 153 
et al., 1996). Rapeseed oil shows high similarity to fish oil and is expected to not 154 
have detrimental effects on fish (Bell et al., 2003 ;Ackman, 1990). Dietary 155 
treatments containing high rapeseed oil levels (19 gm) showed heavier weights for 156 
Atlantic salmon then treatment with lower levels of rapeseed oil. However, when 157 
compared to fish fed marine fish oil no differences in weight were found. Indicating 158 
rapeseed oil does not seem to have detrimental effects. Marine fish meal and fish 159 
oils, being the salmons’ natural diet, had positive effects on fish health (Bell et al., 160 
2003). In addition, marine fish meal and fish oil showed to aid phagocytic ability 161 
and phagocytic capacity (Sørensen et al., 2020).  162 
 163 
Corn gluten affects the appetite of the fish and results in reduced weight 164 
(Fauconneau, 1988; Cowey & Cho, 1992).  165 
 166 
Pea protein concentrate caused Atlantic salmon to experience a decreased nutrient 167 
digestibility and had detrimental effects on growth and intestinal morphology 168 
presenting shortened mucosal folds and an increase in lamina propria widths 169 
(Penn et al., 2011) 170 
 171 
Soybean meal causes enteritis, and morphological changes to the gastrointestinal 172 
tract can already occur as early as 3 weeks into soybean meal exposure  173 
(Baeverfjord & Krogdahl 1996). These effects have been shown to diminish the 174 
immune system’s ability to respond to dietary agitation or pathogens (Baeverfjord 175 
& Krogdahl, 1996; Torrecillas et al., 2015). Soybean has also shown to contain 176 





Antinutrients from plant sources are compounds produced by the plant as a 179 
protective measure against grazing from animals and can cause detrimental 180 
effects when consumed. These compounds can hinder uptake of essential nutrients 181 
and decrease digestibility for lipids. In addition, enteritis, diarrhoea and neoplasia 182 
can occur (Krogdahl et al., 2010; Iwashita et al., 2008).  183 
 184 
Available methodology for tissue analyses 185 
Histology examines the structure and function of separate tissues through the use 186 
of 2D sections, where the sectional orientation is of great influence on the 187 
qualitative evaluation (Ross & Pawlina, 2006). A newly developed technique to 188 
analyse histological samples is mucosal mapping obtained from design-based 189 
stereology. It represents recreation of 3D structures from 2D sections where 190 
directional sectioning is not of importance increasing practical and in vivo 191 
application (Pittman et al., 2011, 2013; Torrecillas et al., 2015; Dang et al., 2019, 192 
2020).  193 
Comparing histological qualification of mucous cells to mucosal mapping several 194 
differences emerged. Samples taken for histology need to precisely run the length 195 
of the epithelia to produce a viable section of 1-2 mm thick slices. Whereas for 196 
mucosal mapping these samples just had to represent 1-2 cm2 of surface area. 197 
Units of measure for histological samples were relative to other structures in the 198 
represented tissue. Mucosal mapping uses universally applicable units of 199 
measure. This means that traditional histological approaches  are not comparable 200 
between different organs and/or treatments, mucosal mapping using universally 201 
applicable measures is standardised and can compare different organs and 202 
treatments in an unbiased manner. As mentioned before sectional orientation was 203 
of great importance for traditional histological approaches, for mucosal mapping 204 
the orientation has no effect (Dang et al., 2020).  205 
 206 
Gastrointestinal tract responses are complex. The mucosal mapping strategy has 207 
given rise to standardised, scalable analyses of barrier tissues, including the 208 
gastrointestinal tract. No standardized method exists to measure and/or analyse 209 
lamina propria. Measuring lamina propria tissue easily subjects to many different 210 
unbiased approaches that are unsuited for large-scale bases. To generate neutral, 211 
accurate and well-balanced results over a large dataset the following protocol, 212 
based on mucosal mapping, was adopted for pilot trial and main trial application.  213 
 214 
The aim of this trial is to investigate how lamina propria, as a tissue, reacts to 215 
different stressors delivered through dietary ingredients.  216 
 217 
It is hypothesised that if fish are treated with various dietary ingredients different 218 
reactional patterns will emerge and when subjected to detrimental ingredients an 219 
increase in lamina propria volumetric density and tissue width will be seen. These 220 
detrimental ingredients are mostly represented by the negative control treatment 221 




Material and method  223 
The feed trial was approved by National Animal Research Authority (Mattilsynet), 224 
Norway (FOTS-ID 14983). Animal husbandry was performed in accordance to 225 
approved protocols.  226 
 227 
For this study Atlantic salmon (Salmo salar) post-smolts were attained from 228 
Cermaq, Hopen, Bodø, Norway (Aquagen strain, Aquagen AS, Trondheim, 229 
Norway) and kept at the Research Station, Nord University, Bodø, Norway.  230 
 231 
Datasets  232 
This trial developed and implemented novel measures for lamina propria on 233 
foregut samples taken from the main trial carried out by Sørensen. et al., 2020.  234 
Analyses of foregut mucous cells has been carried out by Øyen, 2020 containing 235 
data reflecting mucous cell sizes and defence activity. These two datasets were 236 
matched to an individual level (fish ID’s).  237 
 238 
In addition, data for inflammatory cell responses was provided as well by 239 
Sørensen. et al., 2020, containing data concerning phagocytic ability, phagocytic 240 
capacity and lymphocytes. Phagocytic ability relates to number of cells with the 241 
capacity to absorb at least one particle and phagocytic capacity is a measure of 242 
how many particles the cells are able to absorb. For this dataset different fish were 243 
sampled. The data for the inflammatory response was merged per coinciding tank.  244 
 245 
Data for genetic responses was also supplied by Sørensen. et al., 2020 containing 246 
data concerning cathelicidin (CATH1), defensin (DEF3) and mucin (MUC2) 247 
relative gene expression. For this dataset different fish were sampled as well. The 248 




Experimental diets  250 
The trial was composed of five diets: BG1, a fishmeal/fish oil diet mimicking the 251 
natural diet (positive control); BG2, a 20% soybean meal/30% fishmeal & fish oil 252 
diet (negative control); BG3, a fishmeal/rapeseed oil diet; BG4, plant protein 253 
concentrates/fish oil diet; BG5, plant protein ingredients/mix of rapeseed oil & fish 254 
oil diet which resembled commercial diet (Fig. 1).  255 
Fig.1. Diet composition per treatment with weight given in percentages. BG1, fishmeal/fish oil 256 
diet (positive control) mimicking natural diet; BG2, 20% soybean meal/30% fishmeal & fish oil diet 257 
(negative control); BG3, fishmeal/rapeseed oil diet; BG4, plant protein concentrates (main protein 258 
source)/fish oil diet; BG5, plant protein ingredients/mix of rapeseed oil & fish oil diet (commercial 259 




All diets contained supplements with crystalline amino acids (lysine, histidine, 261 
methionine and threonine) and inorganic phosphate. In addition, yttrium oxide 262 
was added to assess digestibility (Table 1).   263 
 264 
Table 1. Diet composition including all ingredients. Units of measure in gm. Each ingredient is 265 
given with coinciding contribution for each treatment group. All diets contained supplements with 266 
crystalline amino acids (lysine, histidine, methionine and threonine) and inorganic phosphate. 267 
Yttrium oxide added for digestibility assessment. 268 
 269 




Experimental set-up  271 
The trial was deployed in a flow-through system containing 1100 fish in total 272 
(initial weight 72.7 ± 1.4 g) (mean ± SD). These were divided over 20 circular 273 
fiberglass tanks with 4 tanks per treatment group, resulting in 220 fish per diet 274 
(Fig. 2). For this study 4 fish from 3 tanks per treatment group were sampled 275 
resulting in 12 samples per diet (n=60).  276 
 277 
Fig. 2. The experimental lab set-up comprised of 20 circular fiberglass tanks, with 4 tanks per 278 
treatment group, 5 treatment groups in total (n=1100). BG1: blue, BG2: red, BG3: yellow, 279 
BG4:orange, BG5: green. For this study 4 fish from 3 tanks per treatment group were sampled 280 
resulting in 12 samples per diet (n=60). For treatment group BG1 tanks T1, T8 & T14 were used. 281 
For treatment group BG2 tanks T6, T7 & T12 were used. For treatment group BG3 tanks T4, T13 282 
& T17 were used. For treatment group BG4 tanks T5, T10 & T15 were used. For treatment group 283 
BG5 tanks T2, T9 & T11 were used. Experiment species: Atlantic salmon (Salmo salar). 284 
 285 
 286 
Fish rearing conditions and environment  287 
Environmental parameters were monitored with a flow rate of 1000L/h, and an 288 
average of 7.6 T, with a salinity of 35 ‰ respectively during a 24-h photoperiod 289 
throughout the experimental trial (65-d). Oxygen saturation was maintained 290 
above 85% (measured at water outlet). Water supply initiated from 250 m depth, 291 
Saltenfjord. Feeding regimes were ad libitum and automated (Arvo Tech, Finland) 292 
with a timeframe of 7 timeslots per 12-h (08:00-10:00, 10:00-12:00, 12:00-14;00, 293 




Biometric measures 295 
All fish were individually weighed (W), and length measured (L), both at 1-d and 296 
65-d, after being anesthetized using tricainemethanesulfonate (MS 222, 140 297 
mg/L). From L and W condition factors (K) were calculated using the Fulton 298 




Trial methodology   300 
General trial methodology 301 
Analysis of the epithelia and the lamina propria was done through the use of VIS, 302 
a histopathological image analysis software for diagnostics (Version 3.6.5.0; 303 
Visiopharm Integrator System), in combination with modified mucosal mapping 304 
as described by Dang et al., 2020.  305 
 306 
Regions of interest (RIO’s) were manually drawn on an image following the 307 
mucosal folds. Then counter frames (CF) were randomly deployed over the image. 308 
Each CF contains two types of stereological probes representing different volumes. 309 
Large probes (1890.41 µm2) represent an area four times the volume of small 310 
probes (472.6 µm2). Since epithelial tissue is present in a much higher volume 311 
then lamina propria tissue, only large probes were used indicating epithelial tissue 312 
and small probes were used indicating lamina propria tissue.  313 
 314 
Lamina propria density ratio 315 
The first method generated lamina propria density ratio (LPr) through registering 316 
epithelial and lamina propria tissue. Epithelial volume (Ev) and lamina propria 317 
volume (LPv) were determined through counts of the particular tissue and the 318 
coinciding probe volume (LPv=LP count*small probe volume/ Ev=E count*large 319 
probe volume). These variables were used to show the proportion of LPv in relation 320 
to Ev calculated through LPr=LPv/Ev which was used for further analyses.   321 
 322 
Lamina propria width  323 
The second method generated lamina propria width (LPwdth). Subsequently to 324 
registering epithelial and lamina propria tissue, lamina propria tissue was 325 
measured in a perpendicular manner to the midline there where a small probe 326 
crossed lamina propria generating LPwdth (Fig. 3).  327 
 328 
Fig. 3. For this trial a method for measuring lamina propria width was developed that measured 329 
lamina propria tissue in a perpendicular manner to the imaginative midline there where a small 330 
probe crossed lamina propria (LPwdth). This midline decided how the 90°-degree angles were 331 
positioned in relation to the direction of the lamina propria.  332 




Pilot trial  334 
The pilot trial used three randomly selected sections of foregut and applied the 335 
stereology methods to measure the mean LPwdth. The pilot results were checked 336 
for reproducibility of mean results, normal distribution and confidence intervals.  337 
 338 
Approximately 200 LPwdth’s were measured per section. From these 200 339 
measurements, three additional groups were created (100-, 50- and 25-340 
measurement groups), to analyse how many measurements were needed per 341 
section. Four totals, of selected unbiased sites for obtaining measures, were plotted 342 
to show a point of stabilisation where confidence intervals would represent similar 343 
results from group to group. The 50-, 100- and 200-groups showed similar 344 
distributions whereas the 25-group showed higher variation between samples 345 
(Fig. 4).  346 
 347 
Fig. 4. Samples were chosen in a blind set-up (n=3). For each sample regions of interest were 348 
manually drawn, and counter frames (CF) were randomly deployed. Per CF epithelial tissue and 349 
lamina propria tissue were registered, registered lamina propria were also width-measured in a 350 
perpendicular manner to a midline. Approximately 200 measurements were attained per sample 351 
and divided in four count groups. These count groups represented 25 measurements (a), 50 352 
measurements (b), 100 measurements (c) and 200 measurements (d). Confidence intervals were 353 
produced per group for assessment of point of stabilisation of the data determining the number of 354 
measures and counting frames needed for statistical accuracy. Experiment species: Atlantic 355 
salmon (Salmo salar).  356 
 357 
 358 
Since stabilisation started from the 50-group a conservative approach was chosen, 359 
due to the novelty of the methods. The 100-group was taken as a baseline since 360 
the 200-group proved time consuming. Average no. measurements per CF was 1 361 




Main trial 363 
The methodology developed in the pilot trial was implemented on the main trial 364 
on all samples (n=60). This was done blind where all information was withheld 365 
except for ID’s.  366 
 367 
Statistical data analysis  368 
Weight was tested through a one-way ANOVA test (Linear mixed effect model 369 
with single categorical predictor; lme)  370 
 371 
Normality was tested by the use of Q-Q plots applied to base-variables L, W, K, 372 
Ecount, EVcount, Ev, LPv, LPwdth and LPratio (Appendix A) 373 
 374 
Significant differences between treatment groups for variables L, W, K, LPr and 375 
LPwdth were identified via independently run clustered linear mixed effect 376 
models (nlme) with a pre-set p < 0.05.  377 
 378 
Correlations between K, LPr, LPwdth and other variables were tested by linear 379 
mixed effect models (nlme) with a pre-set p < 0.05.  380 
 381 




Results  383 
 384 
Biometric measures  385 
The post-smolts had an initial mean W of 72.7 ± 1.4 g (mean ± SD) and a final 386 
mean W of 124.8 ± 14.5 g after a 65-day trial. Treatment group BG2 was 387 
significantly different from all other treatment groups with a lower mean W of 388 
111.7 g (P<.05) (Fig 5.a).   389 
 390 
Mean final L for all treatment groups was 21.4 ± 0.8 cm. Treatment group BG2 391 
had a shorter mean L of 20.9 cm when compared to other treatment groups 392 
(P<.068). Treatment groups did not display significant differences (Fig. 5.b).  393 
 394 
Due to linear relationship between L and W (P<.001), K was chosen for further 395 
analyses. Mean K for all treatment groups was 1.26 ± 0.08 with BG2 representing 396 
lowest mean value of 1.23. (Fig 5.c). Treatment groups did not display significant 397 
differences.  398 
 399 
Fig. 5. At the end of the 65-d trial post-smolt were weighed (W) and lengths measured (L). 400 
Condition factor (K=100·W/L3) was attained though weights and lengths and given per treatment 401 
group. For W treatment group BG2 was significantly different from all other treatment groups 402 
(P<.05). Experiment species: Atlantic salmon (Salmo salar) (n=60).  403 
 404 
















Morphological evaluation  418 
The trial images all presented intestinal folds containing epithelia (yellow cross), 419 
lamina propria (pink thick arrow) and mucous cells (thin white arrow).  A second 420 
reason for providing these images is to serve as an aid to understand upcoming 421 
Ev, LPv, LPr, LPwdth and mucous cell size variables.  422 
 423 
Traditional histological observation shows that treatment group BG3 (Fig. 6.c.) 424 
presents the thinnest lamina propria tissue with little expansion. Expansion is 425 
indicated by white areas appearing in the lamina propria tissue or overall 426 
thickening of the tissue. Treatment group BG2 (Fig. 6.b.) and BG5 (Fig. 6.e.) show 427 
the most expansion indicating an increase in LPwdth. Treatment group BG1 (Fig. 428 
6.a.) and BG4 (Fig. 6.d.) show an increase in LPwdth more than BG3 but less than 429 
BG2 and BG5. LPwdth in traditional histological approaches is where the eye is 430 
drawn and seems to easily indicate swelling which explains why, when referred to 431 
lamina propria tissue reactions in the literature, LPwdth is brought forward as a 432 
variable of interest for further investigation. LPr is unable to establish through 433 
this qualitative approach and for that reason most likely has not received more 434 
attention within the available literature.    435 
 436 
Fig. 6. Reference images for each treatment group were all extracted from the VIS analysis 437 
software with a setting of 40x magnification The trial images all presented intestinal folds 438 
containing epithelia (yellow cross), lamina propria (pink thick arrow) and mucous cells (thin white 439 
arrow).  a. BG2, b. BG2, c. BG3, d. BG4, e. BG5.  440 




Lamina propria  442 
Base measures 443 
This section will focus on the distribution of Ev, LPv, LPr and LPwdth in relation 444 
to the different treatment groups.  445 
 446 
Mean Ev for all treatment groups was 1216353 ± 40074 µm2. Ev showed 447 
significant differences between treatment groups BG3 & BG5 (P<.05), BG1 448 
approached significant difference in relation to treatment group BG5 (P<.075). 449 
Treatment group BG3 showed highest level of Ev and BG5 showed lowest level of 450 
Ev (Fig 7.a).  451 
 452 
Mean LPv for all treatment groups was 78609 ± 26638 µm2. LPv showed no 453 
significant differences between treatment groups but did show a similar trend, to 454 
that observed for epithelial volume, with treatment group BG3 approaching 455 
significant difference from BG5 (P<.095).  Treatment group BG3 showed highest 456 
level of LPv and BG5 showed lowest level of LPv (Fig 7.b). 457 
 458 
All treatment groups showed linear relationships between LPv and Ev (P<.001) 459 
(Fig 7.c). Due to this similarity, further analyses were performed used LPr.  460 
 461 
Fig. 7. Ev=E count*large probe volume (1890.41 µm2). For Ev BG3 & BG5 were significantly 462 
different (P<.05). LPv=LP count*small probe volume (472.6 µm2). A linear relationships was found 463 
between LPv and Ev (P<.001) (R2: 0.79).Experiment species: Atlantic salmon (Salmo salar) (n=60).  464 
 465 
















Mean LPr for all treatment groups was 0.0655 ± 0.0127. LPr showed significant 479 
difference between treatment groups BG3 & BG4 (P<.05), treatment groups BG1 480 
& BG4 showed approaching significant difference (P<.065). Treatment group BG3 481 
represented lowest LPr, meaning proportion of lamina propria tissue was smallest 482 
in relation to epithelia. Treatment group BG4 represented highest LPr meaning 483 
this treatment group represented the highest proportion of lamina propria tissue 484 
in relation to epithelia (Fig. 8.a).  485 
 486 
Mean LPwdth for all treatment groups was 9.4 ± 1.7 µm. LPwdth showed no 487 
significant differences between treatment groups but approached significant 488 
difference between BG3 & BG5 (P<.082). Treatment group BG3 represented 489 
thinnest LPwdth and treatment group BG5 represented broadest LPwdth (Fig. 490 
8.b).  491 
 492 
It is of concern that treatment group BG5, resembling wide-scale commercially 493 
used diets, features elevated LPr and the broadest LPwdth.  494 
 495 
Fig. 8. LPr represents the proportion of lamina propria in relation to epithelia. LPr=LPv/Ev. 496 
For LPr there was significant difference between treatment groups BG3 & BG4 (P<.05). Lamina 497 
propria width represents the mean widths measured for each treatment group (µm). Experiment 498 
species: Atlantic salmon (Salmo salar) (n=60). 499 
 500 





























Lamina propria methodology correlations   527 
 528 
Lamina propria density ratio  529 
This section will focus on the correlations found between LPr and variables within 530 
the biological level of tissue, cell and genes. 531 
 532 
Tissue level correlations 533 
On tissue level correlations were found between LPr and LPwdth and LPr and 534 
mucous cell size.   535 
 536 
Lamina propria density ratio in relation to lamina propria width  537 
A linear relationship was found between LPr and LPwdth, meaning LPr increases 538 
when LPwdth increases. This relationship was approaching significance for 539 
treatment group BG1 (P<.086) (Fig. 9.a) and showed significance for treatment 540 
group BG2 (Fig. 9.b) and for all treatment groups when bundled (P<.05) (R2: 0.07).  541 
 542 
Fig. 9. A linear relationship was found between LPwdth and LPr. This relationship was 543 
approaching significance for treatment group BG1 (P<.086) (R2: 0.27) (n=12) and showed 544 
significance for treatment group BG2 (P<.05) (BG2 R2:0.61, n=12)  and for all treatment groups 545 
when bundled (P<.05) (All R2: 0.07, n=60). Atlantic salmon (Salmo salar). 546 


























Lamina propria density ratio in relation to mucous cell size  570 
Mean mucous cell size for all treatment groups was 202 ± 67 µm. Mucous cell size 571 
showed significant difference between treatment groups BG2 & BG5 (P<.05), BG2 572 
approached significant difference in relation to BG1 (P<.072) (Table 2) (Appendix 573 
C1) (Sørensen et al., 2020). 574 
 575 
LPr in relation to mucous cell size showed a linear relationship for treatment 576 
group BG3 (P<.05) (Fig. 10.). Thus, for this treatment group, LPr increases as 577 
mucous cell size increases. This could mean that a healthy immune system in 578 
reaction to stressors increases in proportion of lamina propria tissue while 579 
simultaneously enlarging mucous cell sizes. 580 
 581 
Fig. 10.  A linear relationship was found between LPr and mucous cell size (µm) for treatment 582 
group BG3 (P<.05) (R2: 0.35). Mucous cell size showed significant difference between treatment 583 
groups BG2 & BG5 (P<.05). Atlantic salmon (Salmo salar). n=12.  584 








Cell level correlations 587 
On cell level correlations were found between LPr and phagocytic ability and LPr 588 
and lymphocytes.   589 
 590 
Lamina propria density ratio in relation to phagocytic ability  591 
Mean phagocytic ability for all treatment groups was 7 ± 4. Phagocytic ability 592 
showed significant difference between treatment group BG1 and all other 593 
treatment groups (P<.05). Treatment group BG1 presented with much higher 594 
phagocytic ability levels then other treatment groups. The other treatment groups 595 
all represented much lower but similar phagocytic ability levels (Table 2: 596 
Appendix E1) (Sørensen et al., 2020).  597 
 598 
It was shown that fish with high dietary fishmeal/fish oil percentages had better 599 
phagocytic ability and phagocytic capacity properties (Sørensen et al., 2020). 600 
Treatment group BG1, containing the highest proportion of  fishmeal/fish oil, 601 
represented significantly higher phagocytic ability and phagocytic capacity than 602 
all other treatment groups (Appendix E1, E4) (Sørensen et al., 2020). 603 
 604 
An inverse relationship was found between LPr and phagocytic ability for 605 
treatment group BG5 (P<.05) (Fig. 11.). Meaning, for this treatment group, that 606 
when LPr increases phagocytic ability decreases.  607 
 608 
Fig. 11. An inverse relationship was found between LPr and phagocytic ability for treatment 609 
group BG5 (P<.05) (R2: 0.33). Phagocytic ability showed significant difference between treatment 610 




Lamina propria density ratio in relation to lymphocytes    612 
Mean lymphocytes for all treatment groups was 32.4 ± 8.6. Lymphocytes showed 613 
significant difference between treatment groups BG1 & BG5 and BG3 & BG5 614 
(P<.05) with treatment group BG3 representing the highest levels of lymphocytes 615 
(Table 2; Appendix E7) (Sørensen et al., 2020). 616 
 617 
A linear relationship was found between LPr & lymphocytes for treatment group 618 
BG3 (P<.05) (Fig. 12.).  Meaning, for this treatment group, that LPr increases as 619 
lymphocytes increases.  620 
 621 
Fig. 12. A linear relationship was found between LPr and lymphocytes for treatment group BG3 622 
(P<.05) (R2: 0.33). Lymphocytes showed significant difference between treatment groups BG1 & 623 
BG5 and BG3 & BG5 (P<.05). Atlantic salmon (Salmo salar). n=12 624 




Gene level correlations 626 
On gene level correlations were found between LPr & CATH1 and LPr & DEF3.   627 
 628 
Lamina propria density ratio in relation to cathelicidin gene expression   629 
Mean CATH1 for all treatment groups was 0.1463 ± 0.2. CATH1 showed no 630 
significant difference between treatment groups but did show approaching 631 
significant difference between treatment groups BG1 & BG3 (P<.066) and BG1 & 632 
BG5 (P<.056) (Table 2: Appendix G1). Treatment group BG3 presented highest 633 
variation (Sørensen et al., 2020).  634 
 635 
An inverse relationship was found between LPr and CATH1 for treatment group 636 
BG1 (P.<05) (R2: 0.37) (Fig. 13.). Meaning, for this treatment group, that when 637 
LPr increases CATH1 decreases. 638 
 639 
Fig. 13. An inverse relationship was found between LPr and cathelicidin relative gene expression  640 
(CATH1) for treatment group BG1 (P<.05) (R2: 0.37). CATH1 showed no significant difference 641 
between treatment groups. Atlantic salmon (Salmo salar). n=12. 642 




Lamina propria density ratio in relation to defensin gene expression   644 
Mean DEF3 for all treatment groups was 0.5 ± 0.6. DEF3 showed significant 645 
difference between treatment groups BG1 & BG2 and BG2 & BG5 (P<.05). In 646 
addition,  close significance was found for BG1 & BG4 (P<.058) and BG2 & BG3 647 
(P<.089) (Table 2; Appendix G7). 648 
 649 
A linear relationship was found between LPr and DEF3 for treatment group BG3 650 
(P.<05) (R2: 0.60) (Fig. 14.). Meaning, for this treatment group, that LPr increases 651 
as DEF3 increases. 652 
 653 
Fig. 14. A linear relationship was found between LPr and defensin relative gene expression 654 
(DEF3) for treatment group BG3 (P<.05) (R2: 0.60). DEF3 showed significant difference between 655 
treatment groups BG1 & BG2 and BG2 & BG5 (P<.05). Atlantic salmon (Salmo salar). n=12 656 




Lamina propria width  658 
This section will focus on the correlations found between LPwdth and variables 659 
within the biological level of tissue, in this case mucous cell size. In addition, 660 
correlations were found for gene level between LPwdth and CATH1 661 
 662 
Tissue level correlations 663 
On tissue level correlations were found between LPr and LPwdth and LPr and 664 
mucous cell size 665 
 666 
Lamina propria width in relation to mucous cell size  667 
LPwdth in relation to mucous cell size showed an inverse relationship with 668 
approaching significance for treatment group BG2 (P<.078) (R2: 0.28). Meaning, 669 
for this treatment group, that when LPwdth increases mucous cell size decreases 670 
(Fig. 15.).   671 
 672 
Previous relationship found for treatment group BG3 showed that mucous cell size 673 
increased with LPr. It was shown as well that for several treatment groups LPr 674 
and LPwdth increase simultaneously. This means that the inverse relationship for 675 
treatment group BG2, showing a decrease in mucous cell size as LPwdth increases, 676 
is opposite to the mucous cell reaction for treatment group BG3.  677 
 678 
This could indicate, since BG2 was meant to apply pressure to the immune system 679 
and create inflammation, that when the immune system has met a threshold that 680 
mucous cell defence is depleted and that mucous cell size decreases resulting in 681 
inflammation, expansion of LPwdth and LPr and ends with a compromised 682 
mucous layer. Treatment group BG2 was known to cause inflammation and poor 683 
health, which was reflected in lowest K and elevated LPr and LPwdth values.  684 
 685 
Fig. 15. A non-significant but close inverse relationship was found between LPwdth (µm) and 686 
mucous cell size for treatment group BG2 (P<.05) (R2: 0.28). Mucous cell size showed significant 687 




Gene level correlations 689 
On gene level correlations were found between LPwdth & CATH1.  690 
 691 
Lamina propria width in relation to cathelicidin gene expression   692 
CATH1 showed no significant difference between treatment groups but did show 693 
approaching significant difference between BG1 & BG3 (P<.066) and BG1 & BG5 694 
(P<.056) (Table 2: Appendix G1). Treatment group BG3 presented highest 695 
variation (Sørensen et al., 2020).  696 
 697 
A linear relationship was found between LPwdth and CATH1 for treatment group 698 
BG5 (P.<043) (R2: 0.35) (Fig. 16.). Meaning, for this treatment group, that LPwdth 699 
increases as CATH1 increases. 700 
 701 
Fig. 16. A linear relationship was found between LPwdth (µm) and CATH1 for treatment group 702 
BG5 (P<.05) (R2: 0.35). CATH1 showed no significant difference between treatment groups. 703 
Atlantic salmon (Salmo salar). n=12 704 
Previously, treatment group BG1 showed an inverse relationship between LPr and 705 
CATH1 meaning as LPr increases CATH1 decreases. As mentioned before LPr and 706 
LPwdth have a linear relationship for several diets. Meaning CATH1 shows 707 
different responses between treatment groups BG1 and BG5.  708 
Treatment groups BG1 and BG5 are significantly different from each other 709 
concerning mean CATH1 per treatment group with BG5 presenting higher 710 
CATH1 levels (Appendix G1). Treatment group BG1, as the positive control, was 711 
considered to not agitate the gastrointestinal tract which was reflected by low LPr 712 
values. Thus, a healthy gastrointestinal tract could be characterised by low levels 713 
of CATH1.  714 
 715 
However, treatment group BG3 which performed best in relation to LPr, LPwdth 716 




Condition factor  718 
This section will focus on the correlations found between K and variables within 719 
the biological level of tissue, cell and genes. 720 
 721 
Tissue level correlations 722 
On tissue level correlations were found between K and LPr.  723 
 724 
Condition factor in relation to lamina propria density ratio  725 
Mean K for all treatment groups was 1.26 ± 0.08 with BG2 representing lowest 726 
mean value of 1.23 and treatment group BG3 representing highest K. Treatment 727 
groups did not display significant differences.  728 
 729 
K in relation to LPr showed a significant inverse relationship for treatment group 730 
BG3 (P<.05) (R2: 0.38) (Fig. 17.). So, for this treatment group, K decreases as the 731 
proportion of lamina propria tissue increases. Meaning that the proportion of 732 
lamina propria tissue decreases when physical health indication improves. This 733 
proportional decrease in lamina propria tissue is confirmed by thin LPwdth for 734 
treatment group BG3.  735 
 736 
Linear relationships between LPr and LPwdth were found for several diets, 737 
meaning low LPr seem to coincide with thin LPwdth. It could be argued that 738 
healthy fish feature thin LPwdth in combination with low LPr.  739 
 740 
Fig. 17. A significant inverse relationship was found between LPr and K for treatment group 741 
BG3 (P<.05) (R2: 0.38). Treatment groups did not display significant differences. Experiment 742 
species: Atlantic salmon (Salmo salar) (n=12). 743 




Cell level correlations 745 
On cell level correlations were found between K & phagocytic ability, K & 746 
phagocytic capacity and K & lymphocytes.  747 
 748 
Condition factor in relation to phagocytic ability   749 
Mean phagocytic ability for all treatment groups was 7 ± 4. Phagocytic ability 750 
showed significant difference between treatment group BG1 and all other 751 
treatment groups (P<.05) (Table 2: Appendix E1) (Sørensen et al., 2020).  752 
 753 
For phagocytic ability and K an inverse relationship was found as well for 754 
treatment group BG4 (P<.05) (R2: 0.37) (Fig. 18.). Meaning as K increases 755 
phagocytic ability decreases.  756 
 757 
Fig. 18. A significant inverse relationship was found between K and phagocytic ability for 758 
treatment group BG4 (P<.05) (R2: 0.37). Phagocytic ability showed significant difference between 759 
treatment group BG1 and all other treatment groups (P<.05). Experiment species: Atlantic salmon 760 
(Salmo salar) (n=12). 761 
 762 




Condition factor in relation to phagocytic capacity  764 
Mean phagocytic capacity for all treatment groups was 1.8 ± 0.1. Phagocytic 765 
capacity showed significant differences between treatment group BG1 and all 766 
other treatment groups (P<.05). In addition, significant difference was found 767 
between treatment groups BG4 & BG5 (P<.05) (Table 2: Appendix E4) (Sørensen 768 
et al., 2020). 769 
 770 
As significance was found for K & phagocytic ability for treatment group BG4, a 771 
similar trend was seen for K & phagocytic capacity for the same treatment group 772 
however, with non-significant values (P<.087) (R2: 0.26) (Fig. 19). Meaning as K 773 
increases phagocytic capacity decreases. 774 
 775 
Fig. 19. A non-significant inverse relationship was found between K and phagocytic capacity for 776 
treatment group BG4 (P<.087) (R2: 0.26). Phagocytic capacity showed significant differences 777 
between treatment group BG1 and all other treatment groups (P<.05). Experiment species: 778 
Atlantic salmon (Salmo salar) (n=12). 779 
 780 
These two correlations found between K and phagocytic ability and capacity for 781 
treatment group BG4 show that both phagocytic ability and capacity decrease as 782 
K increases. A linear relationship was found between phagocytic ability and 783 
phagocytic capacity meaning they increase or decrease simultaneously, supporting 784 
the observation of both phagocytic ability and phagocytic capacity reacting in 785 
similar manners to condition factor for treatment group BG4 (Sørensen et al., 786 
2020) (Appendix F1, F2, F3, F4). This could indicate both phagocytic ability and 787 
capacity increased when fish are in poorer physical condition.  788 
 789 
However, previously an inverse relationship was found between LPr and 790 
phagocytic ability for treatment group BG5. Meaning, for this treatment group, 791 
that when LPr increases phagocytic ability decreases. It was also just shown that 792 




that phagocytic ability would then increase with K, which is opposite to what was 794 
found for treatment group BG4.  795 
 796 
Treatment groups BG4 and BG5 did have similar dietary compositions.  797 
Treatment group BG4 contained higher levels of fish oil than treatment group BG5 798 
but showed the inverse relationship for both phagocytic ability and capacity which 799 
would contrarily have been expected for the other treatment group, if expected at 800 
all. The trends and relationships found for this trial do not sufficiently explain the 801 




Condition factor in relation to lymphocytes  803 
Mean lymphocytes for all treatment groups was 32.4 ± 8.6. Lymphocytes showed 804 
significant difference between treatment groups BG1 & BG5 and BG3 & BG5 805 
(P<.05) (Table 2; Appendix E7) (Sørensen et al., 2020). 806 
 807 
An inverse relationship was found between K & lymphocytes when applied to all 808 
treatment groups (P<.05) (R2: 0.07) (Fig. 20.). Meaning as K increases lymphocytes 809 
decreases. 810 
 811 
Even though this relationships is weak it does confirm previously found linear 812 
relationship between LPr and lymphocytes for treatment group BG3.  813 
 814 
Fig. 20. A significant inverse relationship was found between K and lymphocytes when applied 815 
to all treatment groups (P<.05) (R2: 0.07). Lymphocytes showed significant difference between 816 
treatment groups BG1 & BG5 and BG3 & BG5 (P<.05). Experiment species: Atlantic salmon 817 




Gene level correlations 819 
On gene level correlations were found between K & CATH1.   820 
 821 
Condition factor in relation to cathelicidin relative gene expression 822 
Mean CATH1 for all treatment groups was 0.1463 ± 0.2. CATH1 showed no 823 
significant difference between treatment groups but did show approaching 824 
significant difference between treatment groups BG1 & BG3 (P<.066) and BG1 & 825 
BG5 (P<.056) (Table 2: Appendix G1) (Sørensen et al., 2020).  826 
 827 
An inverse relationship with approaching significance was found between K and 828 
CATH1 for treatment group BG1 (P.<094) (R2: 0.25) (Fig. 21). Meaning as K 829 
increases CATH1 decreases. 830 
 831 
 832 
Fig. 21. A non-significant inverse relationship was found between K and CATH1 for treatment 833 
group BG1 (P<.094) (R2: 0.25). CATH1 showed no significant difference between treatment 834 
groups. Experiment species: Atlantic salmon (Salmo salar) (n=12). 835 
 836 




Condition factor in relation to defensin relative gene expression 838 
Mean DEF3 for all treatment groups was 0.5 ± 0.6. DEF3 showed significant 839 
difference between treatment groups BG1 & BG2 and BG2 & BG5 (P<.05). In 840 
addition,  close significance was found for BG1 & BG4 (P<.058) and BG2 & BG3 841 
(P<.089) (Table 2; Appendix G7). 842 
 843 
An inverse relationship was found between K & DEF3 for treatment group BG3 844 
(P.<05) (R2: 0.48) (Fig.22.). Meaning as K increases DEF3 decreases.  845 
 846 
Fig. 22. A significant inverse relationship was found between K and DEF3 for treatment group 847 
BG3 (P<.05) (R2: 0.48). DEF3 showed significant difference between treatment groups BG1 & BG2 848 
and BG2 & BG5 (P<.05). Experiment species: Atlantic salmon (Salmo salar) (n=12). 849 
 850 
This is confirmed by the previously found linear relationship between LPr and 851 
DEF3 for treatment group BG3 as well. Meaning as LPr increases the DEF3 852 
increases. Indicating that when physical health decreases DEF3 increases.   853 
 854 
It could be stated that CATH1 and DEF3 both increase when LPwdth and LPr 855 
increase as a result of a decreasing K. Peculiarly, treatment group BG3, that 856 
presented with healthy values for LPwdth, LPr and K presented the highest mean 857 
CATH1 value.  858 




Condition factor in relation to mucin relative gene expression 860 
Mean MUC2 for all treatment groups was 0.7 ± 0.3. MUC2 showed significant 861 
difference between treatment group BG2 and all other treatment groups (P<.05) 862 
(Table 2: Appendix G4) (Sørensen et al., 2020).  863 
 864 
A linear relationship was found between K & MUC2 for treatment group BG2 865 
(P.<05 ) (R2: 0.68) (Fig 23.a.), this relationship was also found when applied to all 866 
treatments however with non-significant but approaching values (P<.067) (R2: 867 
0.06) (Fig 23.b.). Meaning, for this treatment group, that K increases as MUC2 868 
increases. 869 
 870 
Fig. 23. A linear relationship was found between K and mucin relative gene expression (MUC2) 871 
for treatment group BG2 (P<.05) (R2: 0.68) (n=12) and a non-significant relationship when applied 872 
to all treatment groups (P<.067) (R2: 0.06) (n=60). MUC2 showed significant difference between 873 































MUC2 is mainly involved in the maintenance of the mucous layer and aid in the 905 
defence against pathogens (Ellis., 2001; Olafsen, 2001). Treatment group BG2 906 
presented significantly lower values for MUC2 than all other diets (Appendix G4) 907 




PCA  909 
A PCA is deemed reliable in interpreting relationships between the different 910 
variables when proportion of variance exceeds 60%. Due to the novelty of the 911 
lamina propria trial it is used for exploratory measures and determination of 912 
future trial endeavours.  913 
 914 
PCA for all treatment groups  915 
Principal component analysis was performed for each diet in relation to all 916 
variables. Proportion of variance did not exceed 22%, meaning only 22% of 917 
proportion of variance is explained by PC1 (Appendix I6). The relationships 918 
indicated were not represented by the correlations found and explained in previous 919 
chapters. However, the PCA when converted to a polygon confirms previous 920 
indications by showing great overlap for treatment groups BG2, BG3, BG4 and 921 
BG5. However, BG1, positive control, showed the least overlap in relation to the 922 
other treatment groups and no overlap with BG2, the negative control (Fig. 24).   923 
 924 
Fig. 24. Polygon representing PCA finding for all treatment groups. Original PCA presented a 925 
proportion of variance of 22% and indicated relationships did not present in correlations explained 926 
in previous chapters, thus was excluded form analyses. Atlantic salmon (Salmo salar). n=60 927 
PCA for all treatment groups including diet composition ingredients  928 
The principal component analysis including all treatment groups and diet 929 
composition ingredients showed a proportion of variance of 42% for PC1, meaning 930 
42% of the variation is explained by PC1.  931 
 932 
PCA showed grouping for MUC2, mucous cell size and condition factor including 933 
rapeseed oil with a possible inverse relationship to CATH1 including fish oil and 934 
extracted soybean meal.  935 
MUC2 and K showed a linear relationships for BG2 confirming this grouping. 936 




LPr for treatment group BG3. However, since LPr showed an inverse relationship 938 
with mucous cell size this grouping was not confirmed.  939 
Phagocytic ability and phagocytic capacity grouped together including wheat flour 940 
with a possible inverse relationship to LPr including wheat gluten. Grouping for 941 
phagocytic ability and phagocytic capacity was confirmed by correlations found 942 
between the two variables (Sørensen et al., 2020).  943 
 944 
Lymphocytes and fish meal grouped together with a possible inverse relationship 945 
to grouping threonine, lysine and methionine.  946 
 947 
LPwdth and defence activity grouped together including soybean protein and pea 948 
protein but did not show a clear possible inverse relationship to any other 949 
groupings (Fig. 25.).  950 
 951 
Fig. 25. PCA finding for all treatment groups including dietary ingredients. Presented a 952 




The principal component analysis including all treatment groups and diet 954 
composition ingredients was transformed to a polygon. This showed distinct 955 
grouping for BG1 & BG3 and BG4 & BG5 with BG2 standing separate from all 956 
other treatment groups, which was supported by previous explained correlations 957 
between LPr and LPwdth and other variables (Fig.26).  958 
 959 
Treatment groups BG1 & BG3 showed similar mean values for LPr, mean 960 
lymphocyte levels and mean defence activity values (Sørensen et al.,2020; Øyen, 961 
2020). Treatment groups BG4 & BG5 showed similar results for mean LPr, K, 962 
mucous cell sizes and defence activity values (Øyen, 2020). Where treatment group 963 
BG2 underperformed for mean K, mucous cell sizes, defence activity, MUC2 levels 964 
and DEF3 levels, although treatment group BG4 showed very low values for DEF3 965 
as well, where all other diets showed higher mean values with more variance 966 
(Sørensen et al.,2020; Øyen, 2020).  967 
 968 
Fig. 26. Polygon representing PCA finding for all treatment groups including dietary ingredients. 969 
Original PCA presented a proportion of variance of 42%. Atlantic salmon (Salmo salar). n=60 970 






Pilot trial  974 
The pilot trial showed a normal distribution for LPwdth and confidence intervals 975 
for the different measurement groups and showed that data stabilised for 50-976 
groups, 100-groups and 200-groups. The methodology showed reproducibility 977 
within the main trial. The same methodology was implemented on hindgut 978 
samples, from the same fish used in this trial, by Øye, 2021. As a control the same 979 
samples that were used in this pilot trial, were analysed by them and produced 980 
similar results meaning the methodology is reproducible and unbiased, their 981 
application showed very stable and similar results to our own trial.   982 
 983 
Main trail 984 
Mean LPwdth for all treatment groups was 9.4 ± 1.7 µm. LPwdth showed no 985 
significant differences between treatment groups but approached significant 986 
difference between BG3 & BG5. Treatment group BG3 represented thinnest 987 
LPwdth and treatment group BG5 represented broadest LPwdth. Treatment 988 
group BG5 showed broadest range for LPwdth.  989 
Treatment group BG4 and BG5 contained high levels of pea protein and corn 990 
gluten. Pea protein has been connected to decreased nutrient digestibility and had 991 
detrimental effects on growth and intestinal morphology presenting shortened 992 
mucosal folds and an increase in lamina propria widths (Penn et al., 2011). This 993 
confirms the observation of high values of LPwdth for treatment group BG5 and 994 
the elevated LPwdth values for treatment group BG4. It was found that corn 995 
gluten affects the appetite of the fish and results in reduced weight (Fauconneau, 996 
1988; Cowey & Cho, 1992). However, this was not seen for these treatment groups 997 
since BG4 and BG5 presented higher K values than BG1 and BG3. Treatment 998 
group BG3, that presented thinnest LPwdth, had high levels of marine fish meal 999 
but had fish oil replaced by rapeseed oil. Rapeseed oil seemed to not have 1000 
detrimental effect since treatment group BG3 presented best values concerning K, 1001 
LPwdth and LPr. That was confirmed by Atlantic salmon fed high levels of 1002 
rapeseed oil and actually increased in weight when rapeseed oil was proportionally 1003 
increased (Bell et al., 2003). No qualitative methods have been developed before 1004 
to measure LPwdth. Up till now LPwdth has been accessed through traditional 1005 
histological observations (Penn et al., 2011). These observations always indicated 1006 
that as inflammation would occur that LPwdth’s would increase in relation to the 1007 
other tissue structures (Penn et al., 2011; Ross & Pawlina, 2006; Baeverfjord & 1008 
Krogdahl 1996).  1009 
 1010 
Mean LPr for all treatment groups was 0.0655 ± 0.0127. LPr showed significant 1011 
difference between treatment groups BG3 & BG4, treatment groups BG1 & BG4 1012 
showed approaching significant difference. Treatment group BG3 represented 1013 
lowest LPr, meaning proportion of lamina propria tissue was smallest in relation 1014 
to epithelia. Treatment group BG4 represented highest LPr meaning this 1015 
treatment group represented the highest proportion of lamina propria tissue in 1016 
relation to epithelia. Treatment group BG5 showed broadest range for LPr. LPr 1017 




between LPR and, for example, dietary ingredients is unknown. The fact that 1019 
treatment group BG3 again presented best values and BG4, which was clustered 1020 
with treatment group BG5, now showed highest levels for LPr shows that 1021 
previously mentioned dietary compositions had similar effects on LPr as on 1022 
LPwdth. This could have been expected since LPr and LPwdth showed to 1023 
simultaneously increase or decrease in reaction to the same stressors.  1024 
 1025 
The only treatment group that showed very different responses from the other 1026 
treatment groups was treatment group BG2. For example, when BG3 showed that 1027 
mucous cell size would increase with LPr, treatment group BG2 showed an 1028 
opposite reactional pattern with mucous cell size decreasing with LPwdth. The 1029 
reactional pattern for treatment group BG3 was confirmed by mucous cell size and 1030 
density ratios that would increase when the gastrointestinal tract was agitated 1031 
(Baeverfjord & Krogdahl 1996). Treatment BG2 was known to cause inflammation 1032 
and poor health which was reflected in lowest K and elevated LPr and LPwdth 1033 
values. But this opposite reaction suggested that when an immune system is 1034 
depleted and meet a threshold that defence mechanisms are not able to respond 1035 
accordingly anymore. This was confirmed by soybean meal being connected to a 1036 
decrease in the immune system’s ability to respond to dietary agitation or 1037 
pathogens (Baeverfjord & Krogdahl, 1996; Torrecillas et al., 2015).  1038 
 1039 
Discrepancies between BG4 and BG5 concerning relationships found for 1040 
phagocytic ability and capacity could not be explained sufficiently by correlations 1041 
available within this trial.  1042 
 1043 
A linear relationship was found between mucous cell size and defence activity for 1044 
treatment group BG5 and when applied to all treatment groups combined 1045 
meaning as mucous cell size increases defence activity is elevated as well 1046 
(Appendix D1, D2). This was supported through treatment group BG5 presenting 1047 
the highest mean mucous cell size values and high defence activity values. This 1048 
could indicate that when the gastrointestinal tract is agitated several defence 1049 
mechanisms are activated like increase in mucous cell sizes, defence activity, 1050 
lymphocytes, phagocytic ability, phagocytic capacity, increase in CATH1, DEF3 1051 
and MUC2 levels (Sørensen et al., 2020; Baeverfjord & Krogdahl 1996; Abós et al., 1052 
2015; Featherstone & Elliss, 1995; Ellis., 2001; Olafsen, 2001; Chang et al., 2006).  1053 
 1054 
Due to the novelty of the lamina propria variables, LPr and LPwdth, finding a 1055 
concise reactional pattern could be challenging due to the number of diets tested. 1056 
For a preliminary trial it could be of interest to minimize the number of treatments 1057 
tested and use two or three extreme diets to elicit different reactional patterns for 1058 
these variables.   1059 
 1060 
One unforeseen problem affected treatment group BG1. This treatment group was 1061 
supposed to represent the natural diet of salmon in the wild but showed 1062 
digestibility (nutrient-uptake) issues (Sørensen et al., 2020). This diet was meant 1063 
to function as a benchmark for other diets to be compared to but due to these 1064 
digestibility issues it is possible that this benchmark function was compromised 1065 




The relative short trial period could have affected these outcomes by prematurely 1067 
terminating the experiment and by that “stunting” the results. The data shows 1068 
many trends and emerging patterns that were crystallising towards definitive 1069 
answers but many of these have not reached fruition. Needless to say, lamina 1070 
propria is in need but also deserves further investigation.  In addition, it is advised 1071 
to include several sampling points to give a better understanding of the 1072 
undergoing changes the tissue goes through during the trial.   1073 
 1074 
The aim of this trial was to investigate how lamina propria, as a tissue, reacted to 1075 
different stressors delivered through dietary ingredients.  1076 
 1077 
Conclusion 1078 
Bases for lamina propria tissue being an aid as an indicator for determination of 1079 
physical health were found. LPr showed higher correlations with other measures 1080 
than LPwdth. The relationships shown through LPr were more conclusive and 1081 
explanatory where LPwdth acted as a supportive measure. In addition, the LPr 1082 
seems better suited for integration with the mucosal mapping technique than 1083 
LPwdth, since LPwdth seems more sensitive to sectional direction. For that 1084 
reason, LPr will create a more well balanced digitalised and automated system 1085 






Abós, B., Castro, R., Granja, A. G., Havixbeck, J. J., Barreda, D. R., & Tafalla, C. 1089 
(2015). Early activation of teleost B cells in response to rhabdovirus infection. 1090 
Journal of virology, 89(3), 1768-1780. 1091 
 1092 
Ackman, R. G. (1990). Canola fatty acids—an ideal mixture for health, nutrition, 1093 
and food use. In Canola and rapeseed (pp. 81-98). Springer, Boston, MA. 1094 
 1095 
Alexander, J. B., & Ingram, G. A. (1992). Noncellular nonspecific defence 1096 
mechanisms of fish. Annual Review of Fish Diseases, 2, 249-279. 1097 
 1098 
Baeverfjord G & Krogdahl A (1996) Development and regression of soybean meal 1099 
induced enteritis in Atlantic salmon, Salmo salar L., distal intestines: a 1100 
comparison with the intestines of fasted fish. J Fish Dis 19, 375 – 387 1101 
 1102 
Bell, J. G., McGhee, F., Campbell, P. J., & Sargent, J. R. (2003). Rapeseed oil as 1103 
an alternative to marine fish oil in diets of post-smolt Atlantic salmon (Salmo 1104 
salar): changes in flesh fatty acid composition and effectiveness of subsequent fish 1105 
oil “wash out”. Aquaculture, 218(1-4), 515-528. 1106 
 1107 
Cabillon, N. A. R., & Lazado, C. C. (2019). Mucosal barrier functions of fish under 1108 
changing environmental conditions. Fishes, 4(1), 2. 1109 
 1110 
Calduch-Giner, J. A., Sitjà-Bobadilla, A., & Pérez-Sánchez, J. (2016). Gene 1111 
expression profiling reveals functional specialization along the intestinal tract of 1112 
a carnivorous teleostean fish (Dicentrarchus labrax). Frontiers in physiology, 7, 1113 
359. 1114 
 1115 
Chang, C. I., Zhang, Y. A., Zou, J., Nie, P., & Secombes, C. J. (2006). Two 1116 
cathelicidin genes are present in both rainbow trout (Oncorhynchus mykiss) and 1117 
atlantic salmon (Salmo salar). Antimicrobial agents and chemotherapy, 50(1), 185-1118 
195. 1119 
 1120 
Cowey, C. B., & Cho, C. Y. (1992). Failure of dietary putrescine to enhance the 1121 
growth of rainbow trout (Oncorhynchus mykiss). Canadian Journal of Fisheries 1122 
and Aquatic Sciences, 49(12), 2469-2473. 1123 
 1124 
Dang, M., Pittman, K., Sonne, C., Hansson, S., Bach, L., Søndergaard, J., ... & 1125 
Nowak, B. (2020). Histological mucous cell quantification and mucosal mapping 1126 
reveal different aspects of mucous cell responses in gills and skin of shorthorn 1127 
sculpins (Myoxocephalus scorpius). Fish & shellfish immunology, 100, 334-344. 1128 
 1129 
Dash, S., Das, S. K., Samal, J., & Thatoi, H. N. (2018). Epidermal mucus, a major 1130 
determinant in fish health: a review. Iranian Journal of Veterinary Research, 1131 





Ellis, A. E. (2001). Innate host defense mechanisms of fish against viruses and 1134 
bacteria. Developmental & Comparative Immunology, 25(8-9), 827-839. 1135 
 1136 
Fauconneau, B. (1988). Partial substitution of protein by a single amino acid or an 1137 
organic acid in rainbow trout diets. Aquaculture, 70(1-2), 97-106. 1138 
 1139 
Featherstone, C., & Elliss, C. (1995). Phagocytosis. Trends Cell Biol. Spec. Issue, 5, 1140 
85-141. 1141 
 1142 
Gatlin, D. M. (2007). Dietary supplements for the health and quality of cultured 1143 
fish. Cabi. 1144 
 1145 
Hellberg, H., Bjerkås, I., Vågnes, Ø. B., & Noga, E. J. (2013). Mast cells in common 1146 
wolffish Anarhichas lupus L.: ontogeny, distribution and association with 1147 
lymphatic vessels. Fish & shellfish immunology, 35(6), 1769-1778. 1148 
 1149 
Iwashita, Y., Yamamoto, T., Furuita, H., Sugita, T., & Suzuki, N. (2008). Influence 1150 
of certain soybean antinutritional factors supplemented to a casein-based 1151 
semipurified diet on intestinal and liver morphology in fingerling rainbow trout 1152 
Oncorhynchus mykiss. Fisheries Science, 74(5), 1075-1082. 1153 
 1154 
Kaattari, S. L., & Irwin, M. J. (1985). Salmonid spleen and anterior kidney harbor 1155 
populations of lymphocytes with different B cell repertoires. Developmental & 1156 
Comparative Immunology, 9(3), 433-444.  1157 
 1158 
Krogdahl, Å., Penn, M., Thorsen, J., Refstie, S., & Bakke, A. M. (2010). Important 1159 
antinutrients in plant feedstuffs for aquaculture: an update on recent findings 1160 
regarding responses in salmonids. Aquaculture research, 41(3), 333-344. 1161 
 1162 
Lazado, C. C., & Caipang, C. M. A. (2014). Mucosal immunity and probiotics in 1163 
fish. Fish & shellfish immunology, 39(1), 78-89. 1164 
 1165 
Liener, I. E., & Kakade, M. L. (1980). Protease inhibitors. Toxic constituents of 1166 
plant foodstuffs, 2, 7-71. 1167 
 1168 
Masso-Silva, J. A., & Diamond, G. (2014). Antimicrobial peptides from fish. 1169 
Pharmaceuticals, 7(3), 265-310. 1170 
 1171 
Meseguer, J., López-Ruiz, A., & Garcí-Ayala, A. (1995). Reticulo-endothelial 1172 
stroma of the head-kidney from the seawater teleost gilthead seabream (Sparus 1173 
aurata L.): An ultrastructural and cytochemical study. The Anatomical Record, 1174 
241(3), 303-309. 1175 
 1176 
Nash, R. D., Valencia, A. H., & Geffen, A. J. (2006). The origin of Fulton’s condition 1177 
factor—setting the record straight. Fisheries, 31(5), 236-238. 1178 
 1179 
Olafsen, J. A. (2001). Interactions between fish larvae and bacteria in marine 1180 




Penn, M. H., Bendiksen, E. Å., Campbell, P., & Krogdahl, Å. (2011). High level of 1182 
dietary pea protein concentrate induces enteropathy in Atlantic salmon (Salmo 1183 
salar L.). Aquaculture, 310(3-4), 267-273. 1184 
 1185 
Plaisancié, P., Barcelo, A., Moro, F., Claustre, J., Chayvialle, J. A., & Cuber, J. C. 1186 
(1998). Effects of neurotransmitters, gut hormones, and inflammatory mediators 1187 
on mucus discharge in rat colon. American Journal of Physiology-Gastrointestinal 1188 
and Liver Physiology, 275(5), G1073-G1084. 1189 
 1190 
Press, C. M., & Evensen, Ø. (1999). The morphology of the immune system in 1191 
teleost fishes. Fish & shellfish immunology, 9(4), 309-318. 1192 
 1193 
Roberts, R. J. (2012). Fish pathology. John Wiley & Sons. 1194 
 1195 
Romarheim, O. H., Hetland, D. L., Skrede, A., Øverland, M., Mydland, L. T., & 1196 
Landsverk, T. (2013). Prevention of soya-induced enteritis in Atlantic salmon 1197 
(Salmo salar) by bacteria grown on natural gas is dose dependent and related to 1198 
epithelial MHC II reactivity and CD8α+ intraepithelial lymphocytes. British 1199 
Journal of Nutrition, 109(6), 1062-1070. 1200 
 1201 
Ross, M. H., & Pawlina, W. (2006). Histology. Lippincott Williams & Wilkins. 1202 
 1203 
RStudio Team (2020). RStudio: Integrated Development Environment for R. 1204 
RStudio, PBC, Boston, MA URL  http://www.rstudio.com/. 1205 
 1206 
Salinas, I., Zhang, Y. A., & Sunyer, J. O. (2011). Mucosal immunoglobulins and B 1207 
cells of teleost fish. Developmental & Comparative Immunology, 35(12), 1346-1208 
1365. 1209 
 1210 
Schroers, V., van der Marel, M., Neuhaus, H., & Steinhagen, D. (2009). Changes 1211 
of intestinal mucus glycoproteins after peroral application of Aeromonas 1212 
hydrophila to common carp (Cyprinus carpio). Aquaculture, 288(3-4), 184-189. 1213 
 1214 
Thompson, K. D., Tatner, M. F., & Henderson, R. J. (1996). Effects of dietary (n-3) 1215 
and (n-6) polyunsaturated fatty acid ratio on the immune response of Atlantic 1216 
salmon, Salmo salar L. Aquaculture Nutrition, 2(1), 21-31. 1217 
Van den Ingh, T. S. G. A. M., Krogdahl, Å., Olli, J. J., Hendriks, H. G. C. J. M., & 1218 
Koninkx, J. G. J. F. (1991). Effects of soybean-containing diets on the proximal 1219 
and distal intestine in Atlantic salmon (Salmo salar): a morphological study. 1220 
Aquaculture, 94(4), 297-305. 1221 
 1222 
Torrecillas, S., Makol, A., Caballero, M. J., Montero, D., Ginés, R., Sweetman, J., 1223 
& Izquierdo, M. (2011). Improved feed utilization, intestinal mucus production and 1224 
immune parameters in sea bass (Dicentrarchus labrax) fed mannan 1225 
oligosaccharides (MOS). Aquaculture Nutrition, 17(2), 223-233. 1226 
Van der Sluis, M., De Koning, B. A., De Bruijn, A. C., Velcich, A., Meijerink, J. P., 1227 




spontaneously develop colitis, indicating that MUC2 is critical for colonic 1229 
protection. Gastroenterology, 131(1), 117-129. 1230 
 1231 
Zapata, A., & Amemiya, C. T. (2000). Phylogeny of lower vertebrates and their 1232 
immunological structures. Origin and evolution of the vertebrate immune system, 1233 
67-107. 1234 
  1235 
Zhu, L. Y., Nie, L., Zhu, G., Xiang, L. X., & Shao, J. Z. (2013). Advances in research 1236 
of fish immune-relevant genes: a comparative overview of innate and adaptive 1237 
immunity in teleosts. Developmental & Comparative Immunology, 39(1-2), 39-62. 1238 
